This live web event has ended. Thank you for attending.
The Alliance for Transparent and Affordable Prescriptions (ATAP)
Wednesday, May 27, 2020 | 1 p.m. ET/ Noon CT/ 11 a.m. MT/ 10 a.m. PT
The Alliance for Transparent and Affordable Prescriptions (ATAP) advocates for increased regulation and oversight of the prescription drug supply chain. Our goal is to bring meaningful reforms to the rebate system. Join us for an in depth look at ATAP’s policy solutions and objectives to improve patient access to affordable treatments. Learn more about trending legislation, laws enacted, and ways your organization can get involved.
Kevin Daley, Naylor Government Affairs
As the director for ATAP, Kevin coordinates both federal and state activities and manages ATAP’s strategic communications, advocacy engagement, and media relations.
Robert Levin, MD, The Alliance for Transparent and Affordable Prescriptions (ATAP)
Since ATAP’s inception, Dr. Levin has served as President. In this role, he leads many state and federal initiatives to reform the prescription drug supply chain and improve patient access to care.
Judith Gorsuch, Hart Health Strategies
Overseeing ATAP’s federal drug pricing legislative and regulatory activities, Judith provides expertise through her role as Vice President and Counsel at Hart Health Strategies, a Washington, D.C. firm. She will speak on the U.S. Supreme Court Case, Rutledge v. Pharmaceutical Care Management Association; as well as provide an update on federal drug pricing and transparency activity.
Heather Kazmark, MA, Naylor Government Affairs
As a government affairs specialist for ATAP, Heather will speak on the 2020 state legislative landscape and provide an overview of ATAP’s state policy initiatives.